82115-62-6

Usage

Uses

Used in Immunotherapy:
Interferon gamma (human lymphocyte protein moiety reduced) is utilized as an immunotherapeutic agent for its ability to modulate the immune system, enhancing the body's natural defense mechanisms against infections and tumors. Its immunomodulatory effects include the activation of macrophages, natural killer cells, and T cells, as well as the promotion of cytokine production and antigen presentation.
Used in the Treatment of Chronic Granulomatous Disease:
In the medical field, interferon gamma (human lymphocyte protein moiety reduced) is employed as a treatment for chronic granulomatous disease, a genetic disorder characterized by impaired neutrophil function, leading to recurrent bacterial and fungal infections. This therapy helps to enhance the phagocytic and microbicidal activities of neutrophils, reducing the frequency and severity of infections in affected individuals.
Used in the Management of Osteopetrosis:
Interferon gamma (human lymphocyte protein moiety reduced) is also used in the management of osteopetrosis, a rare bone disorder where the bone density is abnormally high due to a defect in bone resorption. This treatment promotes the differentiation and activity of osteoclasts, the cells responsible for bone resorption, thereby helping to normalize bone density and structure.
Used in Pharmaceutical Research and Development:
In the pharmaceutical industry, interferon gamma (human lymphocyte protein moiety reduced) is used as a research tool and potential therapeutic agent for various applications. Its antiviral, immunomodulatory, and anti-tumor activities make it a valuable candidate for the development of new drugs and therapies targeting infectious diseases, immune disorders, and cancer.
Used in Drug Delivery Systems:
To improve the delivery, bioavailability, and therapeutic outcomes of interferon gamma (human lymphocyte protein moiety reduced), various drug delivery systems have been developed. These systems, which may include organic and metallic nanoparticles, liposomes, or other carriers, aim to protect the protein from degradation, enhance its stability, and facilitate targeted delivery to specific cells or tissues, thereby maximizing its therapeutic potential.